Millavelez, Bb Girl .
HRN: 26-06-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
10/22/2025
10/29/2025
PO
4ml
Q 12
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes